Zicam Lawsuits – How to Build Your Own Zicam Lawsuit

Law

Since 2006, countless people have filed Zicam lawsuits against the drug maker Matrixx Initiatives for anosmia caused by the drug. These lawsuits have succeeded in getting Matrixx to pay settlements of more than $12 million to Zicam victims. You can build your own Zicam lawsuit by hiring a skilled attorney. Listed below are the steps that you should take to build your case. Hopefully, this article will help you decide whether or not you should pursue a Zicam lawsuit.

Matrixx Initiatives

The plaintiffs in the Zicam lawsuit against Matrixx Initiatives allege that the company’s failure to disclose adverse health events relating to its pharmaceutical drugs violated securities law. The plaintiffs claim that the company failed to disclose a possible connection between the company’s cold remedy and a person’s loss of smell. According to Matrixx, the complaint fails to allege materiality and the issue is therefore not ripe for litigation.

According to the lawsuit, Matrixx’s failure to warn consumers about the risk of side effects posed by Zicam has harmed its business and product’s reputation. The company is facing two lawsuits by consumers who say that the drug has caused them to experience serious adverse reactions. Although Matrixx has denied the allegations, it has refused to settle the cases unless the plaintiffs prevail in the lawsuits.

Matrixx

The Matrixx Initiatives Company is facing a massive lawsuit over its cold remedy, Zicam. The company markets the drug as homeopathic medicine, but some consumers have complained that it’s been linked to an alleged loss of smell. Zicam’s manufacturers say that they merely marketed the product to address patients’ colds. Despite this, some lawsuits filed after the class period have been resolved. Here’s a closer look at the case.

The lawsuit was filed in 2004 and was brought by shareholders who bought stock in the company between Oct. 23, 2003, and Feb. 6, 2004. Shareholders allege that the company breached the Securities and Exchange Act by failing to disclose adverse events related to pharmaceutical drugs. Matrixx argued that it did not violate the law, and the District Court agreed, dismissing the lawsuit. However, the Second Circuit Court of Appeals reversed this decision, finding that the allegations made by the plaintiffs were sufficiently plausible.

Dennis Christenson

Plaintiff Dennis Christensen filed a lawsuit against the manufacturers of the cold remedy Nasal Gel Zicam in 2003. Christensen claims that the nasal spray caused severe stinging and burning sensations in his nose and has permanently impaired his sense of smell. The lawsuit claims that Zicam Cold Remedy does not work and cannot cure a common cold. The company has denied any liability for the lawsuit. Zicam has been a leading brand of cold remedies since 2005.

The spray bottle of the Zicam nasal swabs is too high, causing the gel to contact the olfactory nerve tissue. To remedy this problem, Matrixx designed a new spray bottle with a control tip that would prevent this problem. In the meantime, Matrixx’s advertising campaign featured testimonials from Zicam users, including Rush Limbaugh, who has also sued Matrixx.

Methyl salicylate

The Methyl salicylate found in Zicam is a suspected narcotic that has caused a rash and a loss of smell in some people. Scientists believe that zinc in the drug may be responsible for this condition. Unfortunately, there is no cure for this condition and there are no known alternatives. If you or a loved one suffers from this rash, the best option is to seek medical attention.

According to the Methyl salicylate lawsuit, this drug was mis-sold to consumers. The FDA found that Zicam contained the ingredient methyl salicylate, which is not approved by the FDA. Because the Zicam lawsuits allege that the company knew this ingredient was dangerous, the FDA is reluctant to accept settlements from companies that do not disclose their product’s ingredients. Unfortunately, hundreds of consumers have suffered adverse reactions to the drug.

Zinc gluconate

A new US Supreme Court ruling has opened the door to a Zicam lawsuit against zinc gluconate, a key ingredient in the over-the-counter cold remedy. Matrixx Initiatives, a US-based pharmaceutical company, saw its stock plummet in response to media reports that Zicam had caused anosmia. The company, however, denies that its product is responsible for anosmia and maintains that it did not cause it.

The FDA recently ordered Matrixx Initiatives to cease marketing zinc gluconate, a key ingredient in Zicam. The FDA said that the drug should be properly tested to determine its benefits and safety. The company also warned consumers against using zinc-based products containing the substance. Zicam has been the subject of lawsuits since 2005. The company has apologetically denied the allegations but hasn’t given up yet.

Leave a Reply

Your email address will not be published. Required fields are marked *